Video Experimental Relacionado
Updated: May 13, 2026
08:27
Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
Un nuevo bacteriófago dirigido a la Escherichia coli adherente e invasiva: un agente terapéutico potencial para la
M V Mikhailycheva1, A A Semenov2, N I Borzenko2
1Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical-Biological Agency of Russia, Moscow, Russia. mikhailycheva.mv@phystech.edu.
Bulletin of experimental biology and medicine
|February 10, 2026
Resumen
Un nuevo bacteriófago, vB_EcoA_PHZVL, muestra un gran potencial para el tratamiento de infecciones bacterianas, particularmente en pacientes con enfermedad de Crohn. Su eficacia contra la Escherichia coli adherente invasiva (AIEC) está influenciada por la disponibilidad de nutrientes, lo que afecta a las estrategias de terapia de fagos.
Área de la Ciencia:
- Microbiología Microbiología.
- Virología Virología.
- Gastroenterología y Gastroenterología.
Sus antecedentes:
- El aumento de patógenos multirresistentes a los medicamentos requiere tratamientos innovadores para las infecciones bacterianas.
- La terapia de fagos, utilizando bacteriófagos líticos, ofrece una alternativa específica a los antibióticos.
- La Escherichia coli adherente e invasiva (AIEC) está implicada en la patogénesis de la enfermedad de Crohn (EC).
Objetivo del estudio:
- Para aislar y caracterizar un nuevo bacteriófago con actividad lítica contra AIEC.
- Investigar la influencia de las condiciones de cultivo en las interacciones entre fagos y huéspedes.
- Evaluar el potencial del nuevo fago para aplicaciones terapéuticas en la enfermedad de Crohn.
Principales métodos:
- Aislamiento e identificación de un nuevo bacteriófago, vB_EcoA_PHZVL (familia Autographiviridae).
- Evaluación de la actividad fagolítica frente a una cepa clínica AIEC.
- Análisis de la morfología de la placa y la eficiencia de adsorción de los fagos bajo diferentes medios de cultivo y fuentes de carbono.
Principales resultados:
- vB_EcoA_PHZVL exhibió una potente actividad lítica contra una cepa clínica AIEC de un paciente con enfermedad de Crohn.
- La morfología de la placa fagal y la eficiencia de adsorción se vieron significativamente afectadas por la composición del medio de cultivo y la fuente de carbono.
- Es probable que las variaciones observadas estén relacionadas con alteraciones en la estructura del lipopolisacárido bacteriano (LPS).
Conclusiones:
- vB_EcoA_PHZVL es un candidato prometedor para la terapia de fagos contra las infecciones AIEC.
- La comprensión de la dinámica de fagos y huéspedes, influenciada por las estructuras superficiales bacterianas, es crucial para optimizar la terapia de fagos.
- Esta investigación contribuye al desarrollo de tratamientos dirigidos basados en fagos para la enfermedad de Crohn.
Palabras clave:
La enfermedad de Crohn es la enfermedad de Crohn.Escherichia coli adhesivo-invasivo (AIEC, por sus siglas en inglés)Los bacteriófagos son bacteriófagos.Las despolimerases son las depolímeras.La terapia de fagos es una terapia de fagos.Más Videos Relacionados
07:22Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
08:46T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
Published on: January 26, 2024
Videos de Conceptos Relacionados
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
00:43Lysogenic Cycle of Bacteriophages
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
02:53CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:20Viral Replication: Lytic Cycle
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...